Results 381 to 390 of about 3,443,356 (396)

DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity

DNA Repair, 2015
Atiq Faramarz, Martin A Rooimans, Eunike Velleuer   +2 more
exaly  

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

Cell Reports, 2016
Shawn F Johnson, Daniel G Stover, Kristopher A Sarosiek   +2 more
exaly  

PARP and PARP Inhibitor Therapeutics

2013
openaire   +1 more source

PARP Inhibitors

2006
openaire   +1 more source

DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity

Cell, 2018
Rajat Gupta, Kumar Somyajit, Takeo Narita   +2 more
exaly  

Synthetic inhibitors - PARP inhibitors

2020
openaire   +1 more source

Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer

Future Oncology, 2015
Kathleen N Moore
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Shahneen Sandhu, Johann S De Bono   +2 more
exaly  

Guiding ATR and PARP inhibitor combinations with chemogenomic screens

Cell Reports, 2022
exaly  

BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide

Gynecologic Oncology, 2009
Amber Yasmeen, Michael Pollak, Walter H Gotlieb   +2 more
exaly